Technology development typically begins with an early invention. However, before an invention can enter the market, its commercial viability must be demonstrated. The gap between an early-stage invention and its commercial viability is a critical one.

MBI bridges this gap by using a disciplined de-risking strategy to transform an early-stage discovery into a validated, robust technology package at a meaningful pilot scale. MBI also consolidates the intellectual property position during this de-risking process. The result is a technology package that meets performance, cost, and quality criteria.

As the risks are mitigated and commercial viability is demonstrated, the probability of reaching the market rises, and the value of the technology package escalates rapidly.

As a trusted partner in this technology development process, MBI generates and shares value with all the players in the value chain, from the innovator to commercializer. MBI is willing to share the risk as well as the upside.

[ back to top ]